Journal
BRITISH JOURNAL OF PSYCHIATRY
Volume 221, Issue 2, Pages 488-493Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1192/bjp.2022.34
Keywords
Antidepressants; developmental disorders; intellectual disability; information technologies; polypharmacy
Categories
Ask authors/readers for more resources
Prescribing of psychotropic medications for people with intellectual disability has changed, with antidepressants becoming the most widely prescribed. It is important to understand whether this change is evidence-based and to analyze the benefits or concerns associated with it.
The prescribing of psychotropic medications for people with an intellectual disability has changed. In many locations across England, antidepressants have become the most widely prescribed psychotropic. In the context of the current NHS England STOMP programme to reduce inappropriate psychotropic prescribing for people with intellectual disability, there is an urgent need to understand whether this change reflects evidence-based use of the medications involved. There has been little analysis into the benefits or problems associated with the change and whether it is of concern. This paper offers a variety of possible explanations and opportunities to improve clinical practice and policy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available